logo

AstraZeneca Share | Sustainability & Chart

GB0009895292

Basic information on the AstraZeneca Share

Location: United States

Industry: Health Services

Website

knob-globe
53%

Impact Score

Description AstraZeneca Share

AstraZeneca is a global biopharmaceutical company focusing on the discovery, development, and commercialization of prescription medicines in oncology, rare diseases, and biopharmaceuticals.

AstraZeneca Share Sustainability Performance

Renewable Energy
Greenhouse Gas Emissions
Supply Chain
Waste Recycling
Sustainable
Not yet sustainable
Not sustainable
No data
We measure the sustainability of companies based on 12 criteria. Learn more about our method.

AstraZeneca Share Performance

Chart powered by Eulerpool

Open an account now & invest sustainably

Ready to start investing? Open an account with a broker of your choice now.

Popular Brokers

Logo
Logo
Logo
Logo

Compare AstraZeneca with ...

AstraZeneca

?

Impact Score

knob-globe
53%
knob-globe
0%
Climate
Society
Gender

Sources of sustainability performance

MetricValueUnitYearPDF NamePDF Page
CEO-to-Employee Pay Ratio
CEO namePascal Soriot2023AstraZeneca_AR_2023.pdf108
CEO-to-median-salary-ratio182ratio2023AstraZeneca_AR_2023.pdf126
Employee turnover rate
Employee turnover12,6%2023Sustainability-Report-2023.pdf40
Glass Ceiling
Women in workforce53,9%2023Sustainability-Report-2023.pdf39
Women in management41,7%2023Sustainability-Report-2023.pdf39
Greenhouse Gas Emissions
Number of employees89 900employees2023Sustainability-Report-2023.pdf5
Scope 1 emissions180 898tonnes CO2e2023Sustainability-Report-2023.pdf32
Scope 2 emissions, market based19 940tonnes CO2e2023Sustainability-Report-2023.pdf32
Harassment and Discrimination at the Workplace
Incident notification mechanismNeutral2023AstraZeneca_AR_2023.pdf99
Confidentiality mechanismsNeutral2023AstraZeneca_AR_2023.pdf99
Anti-discrimination policyYes2023Bullying_Harassment_20Feb19.pdf4
Retaliation safeguardsYes2023Bullying_Harassment_20Feb19.pdf2
Renewable Energy
Total renewable energy consumption802 658MWh2023Sustainability-Report-2023.pdf33
Total energy consumption1 511 334(MWh)2023Sustainability-Report-2023.pdf33
Supply Chain
Scope 1 emissions180 898tonnes CO2e2023Sustainability-Report-2023.pdf32
Number of employees89 900employees2023Sustainability-Report-2023.pdf5
Scope 2 emissions, market based19 940tonnes CO2e2023Sustainability-Report-2023.pdf32
Scope 3 emissions6 736 878tonnes CO2e2023Sustainability-Report-2023.pdf33
Recycling and Recovery of Waste
Waste recycled42percentage2023Sustainability-Report-2023.pdf36
Women on the Board
Executive board size2members2023AstraZeneca_AR_2023.pdf121
Women on executive board1members2023AstraZeneca_AR_2023.pdf121
Supervisory board size12members2023AstraZeneca_AR_2023.pdf121
Women on supervisory board4members2023AstraZeneca_AR_2023.pdf121
Women in Management
Women in management41,7%2023Sustainability-Report-2023.pdf39
Note: The PDF pages given here refer to the page in the PDF document, which is not necessarily the one found in the footer of the page. For example, page 10 is the 10th page in the document, even if it is labeled as page 8.

Find more sustainable shares

logo
© 2025 money:care GmbHDisclaimerThe information provided is for informational purposes only and does not constitute an offer, recommendation, or investment advice to buy or sell financial instruments. Nor may they or any part of them be used as a basis for concluding a contract. They have been adopted in good faith from publicly accessible sources. No liability can be assumed for their accuracy. Any financial instrument referred to in this information and documents may be unsuitable for the respective investor to whom it is addressed. The recipients of such information and documents are responsible for independently evaluating and reviewing the products, assets, and financial instruments mentioned therein. Investors must make their own assessment of the suitability of the financial instruments mentioned herein based on the benefits and risks associated with the acquisition of the products, as well as on the basis of their own investment strategy and their legal, tax, and financial situation. Should readers use the content offered or follow any advice, they act on their own responsibility.Price data is provided by Eulerpool Research Systems.The source of ETF data is the websites and data sheets of the respective ETF providers.Logos provided by Clearbit (https://clearbit.com/). All trademarks and logos appearing on this website are the property of their respective owners and are used here for informational and educational purposes only, under fair use guidelines. We claim no affiliation with, nor endorsement by, the companies whose trademarks and logos are displayed. This website is independent of the brands analyzed and receives no direct or indirect compensation from them.The information contained in the company descriptions is generated by artificial intelligence and is for informational purposes only. While we strive for accuracy, the content may not be entirely reliable or comprehensive. We recommend cross-referencing the AI-generated content with other reliable sources to verify it and gain a more comprehensive understanding of the respective companies.Some links are affiliate links. If you click on these links and open an account, we will receive a small commission. Don't worry, you won't incur any additional costs. Thank you for your support!